Willson JK - Search Results

1

Demonstration that mutation of the type II transforming growth factor beta receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells.

Wang J, Sun L, Myeroff L, Wang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JK, et al. Wang J, et al. Among authors: willson jk. J Biol Chem. 1995 Sep 15;270(37):22044-9. doi: 10.1074/jbc.270.37.22044. J Biol Chem. 1995. PMID: 7665626 Free article.

2

Expression of transforming growth factor beta type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells.

Sun L, Wu G, Willson JK, Zborowska E, Yang J, Rajkarunanayake I, Wang J, Gentry LE, Wang XF, Brattain MG. Sun L, et al. Among authors: willson jk. J Biol Chem. 1994 Oct 21;269(42):26449-55. J Biol Chem. 1994. PMID: 7929366 Free article.

3

Growth factor balance and tumor progression.

Brattain MG, Howell G, Sun LZ, Willson JK. Brattain MG, et al. Among authors: willson jk. Curr Opin Oncol. 1994 Jan;6(1):77-81. doi: 10.1097/00001622-199401000-00011. Curr Opin Oncol. 1994. PMID: 8204695 Review.

4

Reduced expression of transforming growth factor beta type I receptor contributes to the malignancy of human colon carcinoma cells.

Wang J, Han W, Zborowska E, Liang J, Wang X, Willson JK, Sun L, Brattain MG. Wang J, et al. Among authors: willson jk. J Biol Chem. 1996 Jul 19;271(29):17366-71. doi: 10.1074/jbc.271.29.17366. J Biol Chem. 1996. PMID: 8663343 Free article.

5

The type II transforming growth factor-beta receptor as a tumor-suppressor gene.

Brattain MG, Markowitz SD, Willson JK. Brattain MG, et al. Among authors: willson jk. Curr Opin Oncol. 1996 Jan;8(1):49-53. doi: 10.1097/00001622-199601000-00009. Curr Opin Oncol. 1996. PMID: 8868100 Review.

6

Role of alpha 5 beta 1 integrin in determining malignant properties of colon carcinoma cells.

Gong J, Wang D, Sun L, Zborowska E, Willson JK, Brattain MG. Gong J, et al. Among authors: willson jk. Cell Growth Differ. 1997 Jan;8(1):83-90. Cell Growth Differ. 1997. PMID: 8993837

7

A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.

Ko Y, Koli KM, Banerji SS, Li W, Zborowska E, Willson JK, Brattain MG, Arteaga CL. Ko Y, et al. Among authors: willson jk. Int J Oncol. 1998 Jan;12(1):87-94. doi: 10.3892/ijo.12.1.87. Int J Oncol. 1998. PMID: 9454891

8

Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells.

Howell GM, Humphrey LE, Awwad RA, Wang D, Koterba A, Periyasamy B, Yang J, Li W, Willson JK, Ziober BL, Coleman K, Carboni J, Lynch M, Brattain MG. Howell GM, et al. Among authors: willson jk. J Biol Chem. 1998 Apr 10;273(15):9214-23. doi: 10.1074/jbc.273.15.9214. J Biol Chem. 1998. PMID: 9535913 Free article.

9

Expression of transforming growth factor-beta receptor type II and tumorigenicity in human breast adenocarcinoma MCF-7 cells.

Ko Y, Banerji SS, Liu Y, Li W, Liang J, Soule HD, Pauley RJ, Willson JK, Zborowska E, Brattain MG. Ko Y, et al. Among authors: willson jk. J Cell Physiol. 1998 Aug;176(2):424-34. doi: 10.1002/(SICI)1097-4652(199808)176:2<424::AID-JCP21>3.0.CO;2-1. J Cell Physiol. 1998. PMID: 9648930

10

Autocrine transforming growth factor alpha provides a growth advantage to malignant cells by facilitating re-entry into the cell cycle from suboptimal growth states.

Jiang D, Yang H, Willson JK, Liang J, Humphrey LE, Zborowska E, Wang D, Foster J, Fan R, Brattain MG. Jiang D, et al. Among authors: willson jk. J Biol Chem. 1998 Nov 20;273(47):31471-9. doi: 10.1074/jbc.273.47.31471. J Biol Chem. 1998. PMID: 9813060 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page